Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Laflamme

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Opinion in Biotechnology|June 21, 2017
Programming cells for cardiac repairRocco Romagnuolo, Michael A Laflamme
The Journal of Thoracic and Cardiovascular Surgery|July 10, 2017
Cardiac repair with pluripotent stem cell-derived cardiomyocytes: Proof of concept but new challengesHassan Masoudpour, Michael A Laflamme
Nature Biotechnology|July 9, 2005
Regenerating the heartMichael A Laflamme, Charles E Murry
Nature|May 20, 2011
Heart regenerationMichael A Laflamme, Charles E Murry
Nature Biomedical Engineering|April 24, 2019
Training heart tissue to matureWahiba Dhahri, Rocco Romagnuolo, Michael A Laflamme
Current Pharmaceutical Design|August 20, 2009
Cardiac applications for human pluripotent stem cellsYuji Shiba, Kip D Hauch, Michael A Laflamme
Stem Cell Research & Therapy|November 26, 2020
The role of regenerative therapy in the treatment of right ventricular failure: a literature reviewChristoph Haller, Mark K Friedberg, Michael A Laflamme
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2011
Methods for the derivation and use of cardiomyocytes from human pluripotent stem cellsWei-Zhong Zhu, Benjamin Van Biber, Michael A Laflamme
Journal of Molecular and Cellular Cardiology|October 26, 2005
Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathwayTodd C McDevitt, Michael A Laflamme, Charles E Murry
Advanced Drug Delivery Reviews|May 19, 2015
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repairMatthew E Hartman, Dao-Fu Dai, Michael A Laflamme
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Opinion in Biotechnology|June 21, 2017
Programming cells for cardiac repairRocco Romagnuolo, Michael A Laflamme
The Journal of Thoracic and Cardiovascular Surgery|July 10, 2017
Cardiac repair with pluripotent stem cell-derived cardiomyocytes: Proof of concept but new challengesHassan Masoudpour, Michael A Laflamme
Nature Biotechnology|July 9, 2005
Regenerating the heartMichael A Laflamme, Charles E Murry
Nature|May 20, 2011
Heart regenerationMichael A Laflamme, Charles E Murry
Nature Biomedical Engineering|April 24, 2019
Training heart tissue to matureWahiba Dhahri, Rocco Romagnuolo, Michael A Laflamme
Current Pharmaceutical Design|August 20, 2009
Cardiac applications for human pluripotent stem cellsYuji Shiba, Kip D Hauch, Michael A Laflamme
Stem Cell Research & Therapy|November 26, 2020
The role of regenerative therapy in the treatment of right ventricular failure: a literature reviewChristoph Haller, Mark K Friedberg, Michael A Laflamme
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2011
Methods for the derivation and use of cardiomyocytes from human pluripotent stem cellsWei-Zhong Zhu, Benjamin Van Biber, Michael A Laflamme
Journal of Molecular and Cellular Cardiology|October 26, 2005
Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathwayTodd C McDevitt, Michael A Laflamme, Charles E Murry
Advanced Drug Delivery Reviews|May 19, 2015
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repairMatthew E Hartman, Dao-Fu Dai, Michael A Laflamme
Pageof 8